| 1994 |
1995 |
1996 |
1997 |
1998 |
|
| Revenues (Millions of Dollars) |
2,559 | 2,713 | 2,770 | 2,811 | 3,117 |
| Gross Profit Margin (Percent) |
45.3 | 47.0 | 48.4 | 49.7 | 50.6 |
| Research and Development Expense (Millions of Dollars) |
144.227 | 144.201 | 154.220 | 180.626 | 217.900 |
| Dividends Per Common Share (Dollars) |
0.19 | 0.21 | 0.23 | 0.26 | 0.29 |
| Book Value Per Share (Dollars) |
5.27 | 5.37 | 5.36 | 5.68 | 6.51 |
| U.S. Revenues (Millions of Dollars) |
1,423.06 | 1,438.46 | 1,423.88 | 1,486.70 | 1,690.28 |
| Non U.S. Revenues (Millions of Dollars) |
1,136.4 | 1,274.1 | 1,345.9 | 1,323.8 | 1,426.6 |
| Medical Segment Revenues (Millions of Dollars) |
1,421.44 | 1,500.08 | 1,509.42 | 1,510.88 | 1,714.95 |
| Diagnostic Segment Revenues (Millions of Dollars) |
1,138.03 | 1,212.45 | 1,260.34 | 1,299.64 | 1,401.92 |
| Gross Profit (Millions of Dollars) |
1,159.83 | 1,276.17 | 1,340.58 | 1,397.21 | 1,575.84 |